CS277291A3 - Pharmaceutical - Google Patents

Pharmaceutical Download PDF

Info

Publication number
CS277291A3
CS277291A3 CS912772A CS277291A CS277291A3 CS 277291 A3 CS277291 A3 CS 277291A3 CS 912772 A CS912772 A CS 912772A CS 277291 A CS277291 A CS 277291A CS 277291 A3 CS277291 A3 CS 277291A3
Authority
CS
Czechoslovakia
Prior art keywords
carbon atoms
optionally substituted
group
amino
halogen
Prior art date
Application number
CS912772A
Other languages
Czech (cs)
English (en)
Inventor
Laar Ben Van
Yvonne Groot
Der Heijden Marja Van
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of CS277291A3 publication Critical patent/CS277291A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS912772A 1990-09-10 1991-09-09 Pharmaceutical CS277291A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90202397 1990-09-10

Publications (1)

Publication Number Publication Date
CS277291A3 true CS277291A3 (en) 1992-04-15

Family

ID=8205113

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912772A CS277291A3 (en) 1990-09-10 1991-09-09 Pharmaceutical

Country Status (8)

Country Link
EP (1) EP0475506A1 (fr)
JP (1) JPH0733652A (fr)
AU (1) AU642524B2 (fr)
CA (1) CA2051034A1 (fr)
CS (1) CS277291A3 (fr)
IE (1) IE913126A1 (fr)
IL (1) IL99426A0 (fr)
ZA (1) ZA917117B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313269D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Allophanic acid derivatives
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
JP5506386B2 (ja) 2006-09-04 2014-05-28 ユニバーシティー・コート・オブ・ザ・ユニバーシティー・オブ・ダンディー P53活性化化合物
JP5369000B2 (ja) * 2007-12-25 2013-12-18 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
GB0909912D0 (en) 2009-06-09 2009-07-22 Univ Dundee Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69621A0 (en) * 1982-09-02 1983-12-30 Duphar Int Res Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
EP0136745B1 (fr) * 1983-09-01 1989-06-07 Duphar International Research B.V Dérivés de benzoylurées à activité antitumorale
EP0262560A3 (fr) * 1986-09-29 1989-07-05 Ishihara Sangyo Kaisha, Ltd. Composés benzoyl urées

Also Published As

Publication number Publication date
EP0475506A1 (fr) 1992-03-18
IL99426A0 (en) 1992-08-18
AU8347791A (en) 1992-03-12
ZA917117B (en) 1992-05-27
IE913126A1 (en) 1992-03-11
AU642524B2 (en) 1993-10-21
CA2051034A1 (fr) 1992-03-11
JPH0733652A (ja) 1995-02-03

Similar Documents

Publication Publication Date Title
EP1561463B1 (fr) prodrogues dérivées de la benzamidoxime en tant qu&#39;agents antipneumocystiques
JP3148284B2 (ja) テトラサイクリン含有医薬組成物
EE200200245A (et) Farmatseutiline kompositsioon, mis sisaldab tolterodiini ja selle kasutamine
NO20033564L (no) Ny formulering med modifisert frigivningsvirkning
BG63821B1 (bg) Фармацевтичен състав на стабилизиран карбапенемовантибиотик и метод за получаване
CS277291A3 (en) Pharmaceutical
EP0292050A1 (fr) Compositions contenant de la flunarizine
CZ290991B6 (cs) Stabilní pevný prostředek obsahující vitamin D3 a trikalciumfosfát
CZ236798A3 (cs) Farmaceutické přípravky obsahující cilansetron stabilizované proti racemizaci
SK284584B6 (sk) Tableta s riadeným uvoľňovaním
JP2013221029A (ja) ピタバスタチンの安定した製剤
US4895851A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
PT1121109E (pt) Formulacao bifasica contendo tramadol
US20020037899A1 (en) Compositions containing an inhibitor of dihydrofolate reductase and a folate
JP2000204037A (ja) 筋萎縮性側索硬化症治療薬
JP6963651B2 (ja) エピナスチン又はその塩を含有する水性組成物
JP2003533464A (ja) 安定化ステロイド懸濁液
NZ514353A (en) Combination preparation for treating malaria
CA1132906A (fr) Additif vermifuge a faible volume pour nourriture pour chevaux
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
KR20010031911A (ko) 약제용 서방화제 및 그것을 함유한 서방성 의약조성물
US10369129B2 (en) Long acting pharmaceutical composition of protease inhibitor
CZ281286B6 (cs) Prostředek obsahující verapamil a trandolapril
TWI678203B (zh) 蛋白酶抑制劑之長效醫藥組合物
EP3463374A1 (fr) Composition pharmaceutique à action prolongée à base d&#39;un inhibiteur de protéase